← Open Payments lookup

TRAVIS DEANGELIS: Open Payments

NPI 1598506990 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$475 in 20 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $475

Food & beverage: $475
CompanyPaymentsAmount
Axsome Therapeutics, Inc.3$92
Alkermes, Inc.3$73
Janssen Pharmaceuticals, Inc2$52
ABBVIE INC.2$51
Neurocrine BioSciences, Inc.2$48
E.R. Squibb & Sons, L.L.C.2$45
Teva Pharmaceuticals USA, Inc.2$33
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$30
Otsuka America Pharmaceutical, Inc.1$22
Supernus Pharmaceuticals, Inc.1$15

Products named: Auvelity, INVEGA SUSTENNA, VRAYLAR, INGREZZA, COBENFY, VIVITROL, ARISTADA, UZEDY.

Industry payments across CO — which companies pay providers there.